Verve Therapeutics
Derek Cerchione is a senior scientist, protein engineering at Verve Therapeutics, with expertise in developing new methods to create novel gene editing enzymes. Prior to joining Verve, he worked at Tessera Therapeutics, Arbor Biotechnologies, and Editas Medicine, where he focused on building pipelines to engineer unique nucleases with novel PAMs, increased fidelity, and higher editing efficiencies. He received his B.S. in Biology from Rensselaer Polytechnic Institute and his M.A. in Biology from Johns Hopkins University.
This person is not in any teams
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.